The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Development of life-expectancy tables for people with type 2 diabetes
Open accessAbstract
AIMS: To develop tables that report the life expectancy associated with levels of major modifiable risk factors for patients with type 2 diabetes. METHODS AND RESULTS: A set of tables reporting life-expectancy stratified by age-sex groups for combinations of modifiable risk was constructed based on predictions from the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. This model is based on a system of parametric proportional hazards risk equations for estimating mortality and vascular complications of diabetes that have been estimated from 3642 patients from the UKPDS. The tables show substantial potential gains in life expectancy within every age group from modifying major risk factors. The estimated life expectancy of men at age of 55 years with type 2 diabetes, 5 years after diagnosis, varies between 13.2 years for a patient who smokes, has systolic blood pressure of 180 mmHg, a total:HDL cholesterol ratio of 8, and HbA(1c) of 10%, and 21.1 years for a non-smoker with SBP of 120 mmHg, total/HDL ratio of 4, and HbA(1c) of 6%. CONCLUSION: Life expectancy tables provide a potentially useful tool of conveying prognostic information to people with type 2 diabetes and suggest substantial scope for increasing longevity by improving modifiable risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardiovascular disease (CVD) accounts for 75% of all related deaths in diabetic patients and on average individuals with T2D have an increased risk of shorter life expectancy.44,45”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [45]
In the citing paper
“By contrast, the UKPDS-OM2 takes a completely transparent approach [6, 26], in which we have fully reported its development, the equations that determine all outcomes and the algorithm used to bring the elements of the model together.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
The J-Curve Phenomenon in Hypertension
Kang, Y., & Wang, J. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,551
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881
Research works printed but not linked: 1
- 1995, Mortality in non-insulin-dependent diabetes, 233
Cited by
Sorted by citations
Items 101–127 of 127
Munshi, V. N., Saghafian, S., Cook, C. B., Aradhyula, S. V., & Chakkera, H. A. (2021) · Annals of Transplantation · doi:10.12659/aot.928624 · Cited by 3
Csóka, B., Pacher, P., Bai, P., & Haskó, G. (2015) · Diabetes · doi:10.2337/db15-0437 · Cited by 3
Khan, A. A., Chung, M. J., Novak, E. L., & Brown, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005946 · Cited by 4
The Business of Intensive Insulin Therapy for Type 2 Diabetes Patients: Where It all Began for Me
Norton, E. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300635 · Cited by 2
Gao, L., Nguyen, D., Moodie, M., Brennan, A., Dinh, D. T., Reid, C. M., Duffy, S. J., Clark, D., Hiew, C., Qqueli, E., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.10.045 · Cited by 2
PRO: Older Adults Should Be Offered Liver Transplantation
Haque, L., Palumbo, C. S., & Batisti, J. (2019) · Clinical Liver Disease · doi:10.1002/cld.821 · Cited by 2
Shao, H., Laxy, M., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Value in Health · doi:10.1016/j.jval.2020.09.010 · Cited by 1
A report of two cases of type 2 diabetes mellitus (T2DM): happy and longevity
Sinorita, H., Sutarni, S., & Gofir, A. (2022) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005404202211 · Cited by 1
Cuidados paliativos domiciliarios en enfermedades crónico-degenerativas y catastróficas
Guerrero, D. L. E. G., Carriel, O. A. R., & Llumitaxi, S. J. P. (2019) · Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida · doi:10.35381/s.v.v3i1.533 · Cited by 1
Sawhney, A. G., & Rothkopf, M. M. (2014) · CRC Press eBooks · doi:10.1201/b17616-7 · Cited by 2
Stamatikos, A., Davis, J. E., Shay, N. F., Ajuwon, K. M., Deyhim, F., & Banz, W. J. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000547 · Cited by 1
Little, J. W., Falace, D. A., Miller, C. S., & Rhodus, N. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08028-6.00014-2 · Cited by 1
100 years of insulin: victories, hopes, and existing challenges
Pierzchała, K., & Scanes, C. G. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0081 · Cited by 1
Targeting Matrix Metalloproteinase 2 and 9 for Treatment of Cardiovascular Dysfunction of Diabetes
Bhatt, L. K., & Addepalli, V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_23
Rydén, L., Grant, P. J., Bax, J. J., Fagard, R. H., Ferrari, R., Hasdai, D., Hoes, A. W., Kirchhof, P. F., Piepoli, M. F., Torbicki, A., et al. (2014)
Haas, A. V., Peng, S., Menh, P., Ngoun, S., Curran, P., McDonnell, M. E., & Hudson, M. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0057
NUTRITION, LABORATORY AND NON-LABORATORY INDICATORS AND ITS VARIOUS VALUES (ATTRIBUTES)
Nake, A. (2020) · International Journal of Ecosystems and Ecology Science (IJEES) · doi:10.31407/ijees10.132
Risk-Based Strategies for Population Screening and Disease Management
Munshi, V. N. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Preuss, H. G., & Bagchi, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821232-5.00017-3
Kuo, R. Y. L., Ng, M., Prieto‐Alhambra, D., & Furniss, D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007826
Therapieziele und Lebenserwartung bei Diabetes mellitus Typ 2
Pavlicek, V. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00917-1
Lebenserwartung bei Diabetes steigt durch Erreichen der Therapieziele
Müssig, K. (2022) · Info Diabetologie · doi:10.1007/s15034-022-3864-8
Singh, S., Rivero‐Arias, O., & Clarke, P. (2025) · Value in Health · doi:10.1016/j.jval.2025.03.021
Self-citationSi, S., Wang, R., Li, J., Ding, Y., Liu, Y., & Osumili, B. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2025.2604454
Morbidity-Based Pension Benefit Evaluation and Payment Option Comparison
Zhai, D., Feng, Y., Niu, G., Bishop, J., & Quinn, J. T. (2026) · Journal of risk and financial management · doi:10.3390/jrfm19010088
A Deep Learning Prognostic Model for Diabetes Patients Using Bilateral Fundus Imaging
Lai, Y.-M., Chung, I.-F., Huang, S.-H., Sheu, W. H., Liang, K.-H., & Chen, H.-S. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261434035
Pîrșcoveanu, D. F. V., Pluta, I. D., Dîrnu, R., Vlădulescu, C., Trașcă, D.-M., Văruț, R. M., Kamal, A. M., Stoica, M., Pura, G., Popa, R., et al. (2026) · Molecules · doi:10.3390/molecules31142415
Metadata
- Authors
- Leal, J., Gray, A. M., & Clarke, P. M.
- Affiliations
- University of Oxford (GB)
- The University of Sydney (AU)
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-24
- Volume
- 30
- Issue
- 7
- Pages
- 834-839
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC2663724
- OpenAlex
- W2107098508
- Cited by
- 128
- References
- 40
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 9 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 13 · 2013: 12 · 2012: 3
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetes Australia
- Medical Research Council
- National Health and Medical Research Council (512463)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, life expectancy, modifiable risk factors, mortality prediction, vascular complications, smoking, systolic blood pressure, TC/HDL-C ratio, HbA1c, prognosis
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Health Status, Health Surveys, Humans, Life Expectancy, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
